Literature DB >> 2956151

Estrogen cholestasis. Membranes, metabolites, or receptors?

M Vore.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2956151

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  15 in total

1.  The role of SAMe in the treatment of liver disease.

Authors:  R Williams; C S Lieber
Journal:  Drugs       Date:  1990       Impact factor: 9.546

2.  Oestradiol 17 beta-glucuronide and tight junctional permeability increase.

Authors:  R Coleman; K S Kan
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

3.  The pathophysiological significance of increased tight-junctional permeability during oestrogen cholestasis.

Authors:  H Jaeschke
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

Review 4.  Pathophysiology and clinical basis of prevention and treatment of complications of chronic liver disease.

Authors:  S Wagner; H U Lautz; M J Müller; F W Schmidt
Journal:  Klin Wochenschr       Date:  1991-02-06

5.  Oestradiol 17 beta-glucuronide increases tight-junctional permeability in rat liver.

Authors:  K S Kan; M J Monte; R A Parslow; R Coleman
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

Review 6.  Cellular mechanisms of intrahepatic cholestasis.

Authors:  P J Meier-Abt
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 7.  Role of S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis.

Authors:  P Almasio; M Bortolini; L Pagliaro; M Coltorti
Journal:  Drugs       Date:  1990       Impact factor: 9.546

8.  Induction of hepatic multidrug resistance-associated protein 3 by ethynylestradiol is independent of cholestasis and mediated by estrogen receptor.

Authors:  María L Ruiz; Juan P Rigalli; Agostina Arias; Silvina Villanueva; Claudia Banchio; Mary Vore; Aldo D Mottino; Viviana A Catania
Journal:  Drug Metab Dispos       Date:  2012-10-17       Impact factor: 3.922

Review 9.  S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism.

Authors:  H A Friedel; K L Goa; P Benfield
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

10.  Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver.

Authors:  R Bossard; B Stieger; B O'Neill; G Fricker; P J Meier
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.